These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1121 related items for PubMed ID: 16351799

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 24. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y, Shi YK, He XH, Yang JL, Yang S, Yu YX, Li B, Wang QL, Zhou LQ, Sun Y.
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C.
    Cancer J Sci Am; 1997 Apr; 3(5):303-11. PubMed ID: 9327155
    [Abstract] [Full Text] [Related]

  • 27. [Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].
    Yao B, Li YX, Fang H, Yu ZH, Jin J, Liu XF.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):222-5. PubMed ID: 16875550
    [Abstract] [Full Text] [Related]

  • 28. Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results.
    Orlandi E, Lazzarino M, Brusamolino E, Castelli G, Pagnucco G, Morra E, Bernasconi C.
    Haematologica; 1991 Apr; 76(3):204-8. PubMed ID: 1743590
    [Abstract] [Full Text] [Related]

  • 29. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY, Zhao XM, Cao JN, Hu XC, Yin JL, Hong XN, Li J.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
    [Abstract] [Full Text] [Related]

  • 30. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
    Niibe Y, Hayakawa K, Kitano M, Ishiyama H, Nakayama M, Yao K, Okamoto M.
    Anticancer Res; 2005 Mar; 25(6C):4403-6. PubMed ID: 16334116
    [Abstract] [Full Text] [Related]

  • 31. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
    Lambertenghi Deliliers G, Butti C, Baldini L, Ceriani A, Lombardi F, Luoni M, Montalbetti L, Pavia G, Pinotti G, Pogliani E.
    Haematologica; 1995 Mar; 80(4):318-24. PubMed ID: 7590500
    [Abstract] [Full Text] [Related]

  • 32. [MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
    Fan Y, Huang ZY, Luo LH, Yu HF.
    Ai Zheng; 2005 Dec; 24(12):1503-6. PubMed ID: 16351801
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
    Zhang HY, Lin TY, Jiang WQ, Zhang L, Huang HQ, Xia ZJ, Sun XF, He YJ, Guan ZZ.
    Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
    [Abstract] [Full Text] [Related]

  • 35. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
    Escalón MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, Dang NH.
    Cancer; 2005 May 15; 103(10):2091-8. PubMed ID: 15816054
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.
    Srp Arh Celok Lek; 1998 May 15; 126(9-10):345-8. PubMed ID: 9863405
    [Abstract] [Full Text] [Related]

  • 37. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
    Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, Lu N, Yu ZH.
    J Clin Oncol; 2006 Jan 01; 24(1):181-9. PubMed ID: 16382127
    [Abstract] [Full Text] [Related]

  • 38. [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
    Li YH, Jiang WQ, Huang HQ, Xu RH, Lin TY, Xia ZJ, He YJ, Guan ZZ.
    Ai Zheng; 2003 Apr 01; 22(4):401-3. PubMed ID: 12703998
    [Abstract] [Full Text] [Related]

  • 39. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy.
    Kim K, Chie EK, Kim CW, Kim IH, Park CI.
    Jpn J Clin Oncol; 2005 Jan 01; 35(1):1-5. PubMed ID: 15681596
    [Abstract] [Full Text] [Related]

  • 40. [Weekly CHOP chemotherapy in the treatment of intermediate-grade non-Hodgkin's lymphomas--cooperative group study by seven institutes].
    Kobayashi M, Sao H, Mizuta S, Kamiya O, Ohara K, Nagata K, Takeyama H, Watanabe E, Yamada H, Mizuno H.
    Rinsho Ketsueki; 1990 Oct 01; 31(10):1656-63. PubMed ID: 2255056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.